• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec10
Kura Oncology Director Faheem Hasnain Disposes of Common Stock
21:05
Dec8
Kura Oncology and Kyowa Kirin Announce Positive Results of KOMET-007 Trial of KOMZIFTI in Treatment of Acute Myeloid Leukemia
15:30
Dec3
Kura Oncology to Host Virtual Meeting to Discuss Acute Myeloid Leukemia Drug Treatment Data
13:32
Dec2
Kura Oncology Completes First Commercial Sale in the US Post FDA Approval
13:03
Nov25
Kura Oncology Receives FDA Approval for KOMZIFTI™
22:17
Nov15
Kura Oncology Inc Official Submits Form 144 to Sell Restricted Stock
01:06

Schedules & Filings

Schedules
Filings
Nov4
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 20.75 M, Net Income -74.12 M, EPS -0.8456

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 15.29 M, Net Income -66.12 M, EPS -0.7549

May1
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 14.11 M, Net Income -57.43 M, EPS -0.6569

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More